The depletion of KIF18A showed a trend toward increased cyclin B1 (G2M marker) and cl-PARP (apoptosis marker) protein levels as well as decreased MCL-1 (a pro-survival marker) protein levels in those cancer cell lines sensitive to KIF18A KD in our cell growth assay (Fig. 1e). The gene discussed is MCL1; the disease is cancer.